Navigation Links
Inovio Pharmaceuticals' Leadership for Life Sciences Recognized in the Philadelphia Region
Date:10/6/2011

e University of Pennsylvania and was VGX's CEO. In a span of less than 10 years, Dr. Kim has guided the advancement of a new type of vaccine, called a synthetic vaccine, from early research into Phase II clinical trials.

Dr. Kim said, "Inovio is proud to receive recognition as a Life Sciences Company of the Year in the Philadelphia region. This award validates our approach to discover, develop and commercialize a new generation of vaccines – synthetic vaccines – that hold the promise to treat and prevent HIV, seasonal and pandemic influenza, and cervical cancer, along with other challenging diseases."

About Inovio Pharmaceuticals, Inc.

Inovio is developing its revolutionary synthetic consensus immunogen technologies to extend the profound medical benefits of the 20th century's immune-system-stimulating vaccines by preventing and treating today's cancers and challenging infectious diseases. Its SynCon® vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery method, have been shown in humans to be safe and generate best-in-class immune responses. Inovio's clinical programs include Phase II studies for cervical dysplasia/cancer, leukemia and hepatitis C virus and Phase I studies for influenza and HIV. Partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, US Dept. of Homeland Security and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene deli
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
2. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
3. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
4. Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
5. Inovio Pharmaceuticals to Present at Investor Conferences
6. Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results
7. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
8. Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board
9. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
10. Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
11. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... BRUNSWICK, N.J., Nov. 28, 2011  Johnson & Johnson (NYSE: ... Annual Health Care Conference on Tuesday, Nov. 29 th at ... Chairman, Ethicon will present in a session scheduled at 8:00 a.m. ... investors and other interested parties by accessing the Johnson & Johnson ...
... 2011 The National Association of Drug Diversion ... cooperation between law enforcement, healthcare professionals, state regulatory ... investigation of drug diversion – today applauded the ... Exchange (NPLEx) demonstrating the real-time, stop-sale system in ...
Cached Medicine Technology:Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones 2
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/17/2014)... It,s estimated that as many as 10 million older ... of loneliness and isolation. , However, new research ... retired older Americans for six years found that ... of depression by more than 30 percent. , "That,s ... State University professor of telecommunication, information studies and media ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... NEW YORK, May 16, 2012 -- A collaboration to ... children is being launched by Cincinnati Children,s Hospital Medical ... Negev (BGU) in Beer-Sheva, Israel. The goal is to ... that is customized to meet childrens, unique physiological differences ...
... May 16, 2012The inaugural issue of BioResearch ... access journal, was released today by Mary Ann ... rapid-publication forum for a broad range of scientific ... cellular biology, tissue engineering and biomaterials, regenerative medicine, ...
... Breast cancer stem cells wear a cell surface protein ... as potent tumor-generating cells and flagging their vulnerability to a ... Center report online in Journal of Clinical Investigation . ... stem cells and also found that it,s targetable with a ...
... has replaced another minimally invasive operation as the main ... the diseased organ, and with comparable results, according to ... While the study shows that robot-assisted partial nephrectomy ... complications than laparoscopic partial nephrectomy (LPN), the researchers cautioned ...
... undergo radical surgery for prostate cancer may expect better ... hospitals with residency programs, and better still if the ... study by Henry Ford Hospital. The study, which ... throughout the U.S., also found that those with fewer ...
... Black prostate cancer patients may not be getting ... to a first-of-its-kind study by researchers at Henry Ford ... surgery to remove diseased prostates. While it is ... why the results of radical prostatectomy are not as ...
Cached Medicine News:Health News:Ben-Gurion U. and Cincinnati Children's Hospital to develop pediatric-specific medical technologies 2Health News:Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers 2Health News:Scientists discover marker to identify, attack breast cancer stem cells 2Health News:Scientists discover marker to identify, attack breast cancer stem cells 3Health News:Scientists discover marker to identify, attack breast cancer stem cells 4Health News:Robot-assisted surgery now favored treatment for kidney cancer 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Quality of care, other issues may cause worse results in black prostate cancer surgery patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: